Cobimetinib and trametinib inhibit platelet MEK but do not cause platelet dysfunction.

Saved in:
Bibliographic Details
Title: Cobimetinib and trametinib inhibit platelet MEK but do not cause platelet dysfunction.
Authors: Unsworth AJ; a Institute for Cardiovascular and Metabolic Research , University of Reading, School of Biological Sciences , Reading , UK., Bye AP; a Institute for Cardiovascular and Metabolic Research , University of Reading, School of Biological Sciences , Reading , UK., Kriek N; a Institute for Cardiovascular and Metabolic Research , University of Reading, School of Biological Sciences , Reading , UK., Sage T; a Institute for Cardiovascular and Metabolic Research , University of Reading, School of Biological Sciences , Reading , UK., Osborne AA; a Institute for Cardiovascular and Metabolic Research , University of Reading, School of Biological Sciences , Reading , UK., Donaghy D; b Department of Microbiology Immunology and Pathology , Colorado State University , Fort Collins , CO , USA., Gibbins JM; a Institute for Cardiovascular and Metabolic Research , University of Reading, School of Biological Sciences , Reading , UK.
Source: Platelets [Platelets] 2019; Vol. 30 (6), pp. 762-772. Date of Electronic Publication: 2018 Sep 25.
Publication Type: Journal Article
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 9208117 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1369-1635 (Electronic) Linking ISSN: 09537104 NLM ISO Abbreviation: Platelets Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1369-1635
DOI:10.1080/09537104.2018.1514107